A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Solid Tumors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Hu Xingsheng)
  • Fujian Cancer Hospital, Fuzhou, Fujian, China

    Contact: Study coordinator (Guo Zengqing)
  • Fujian Cancer Hospital, Fuzhou, Fujian, China

    Contact: Study coordinator (Huang Zhangzhou)
  • Fujian Medical University Union Hospital, Fuzhou, Fujian, China

    Contact: Study coordinator (Lai jinhuo)
  • The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

    Contact: Study coordinator (Wu Jingxun)
  • The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China

    Contact: Study coordinator (Li Bihui)
  • Guangxi Medical University Cancer Hospital & Guangxi Cancer Institute, Nanning, Guangxi, China

    Contact: Study coordinator (Zhang Qingyun)
  • Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China

    Contact: Study coordinator (Wang guangyu)
  • Anyang Cancer Hospital, Luoyan, Henan, China

    Contact: Study coordinator (Ji yuanyuan)
  • The First Affiliated Hospital of Henan University of Science &Technology, Luoyang, Henan, China

  • Nanyang Second General Hospital, Nanyang, Henan, China

    Contact: Study coordinator (Wang Qichuan)
  • The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China

    Contact: Study coordinator (Ji Yinghua)
  • The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

    Contact: Study coordinator (Jin shuiling)
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China, Wuhan, Hu'Nan, China

    Contact: Study coordinator (Zhang tao)
  • Hubei Cancer Hospital, Wuhan, Hubei, China

    Contact: Principal Investigator (Liang xinjun)
    Contact: Principal Investigator (Yang bin)
  • Tongji Hospital, Tongji Medical College of HUST, China, Wuhan, Hubei, China

    Contact: Study coordinator (Chu qian)
  • Hunan Cancer Hospital, Changsha, Hunan, China

    Contact: Study coordinator (Liu Zhenyang)
  • Hunan Cancer Hospital, Changsha, Hunan, China

    Contact: Study coordinator (Jiang Shusuan)
  • Hunan Cancer Hospital, Changsha, Hunan, China

    Contact: Study coordinator (Ouyang Quchang)
  • Hunan Cancer Hospital, Changsha, Hunan, China

    Contact: Study coordinator (Wu lin)
  • Jiangsu Province Hospital, Nanjing, Jiangsu, China

    Contact: Study coordinator (Gu yanhong)
  • The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China

    Contact: Study coordinator (Zhang Wenhui)
  • Xuzhou Central Hospital, Xuzhou, Jiangsu, China

    Contact: Study coordinator (Han liang)
  • The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

    Contact: Study coordinator (Sun Longhua)
  • Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China

    Contact: Study coordinator (Liu Hongxv)
  • The first Hospital of China Medical University, Shenyang, Liaoning, China

    Contact: Study coordinator (Zhao Mingfang)
  • Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Chen Zhiyu)
  • Zhongshan Hospital, Fudan University, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Yu yiwei)
  • West China Hospital of Sichuan University, Chengdu, Sichuan, China

    Contact: Study coordinator (Li mei)
  • Yunnan Tumor Hospital, Kunming, Yunnan, China

    Contact: Study coordinator (Yang Runxiang)
  • Sir Run Run Shaw Hospital, affiliated with Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Fang yong)
  • Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

    Fanyun
  • Taizhou Hospital of Zhejiang Province, Taizhou, Zhejiang, China

    Contact: Study coordinator (Lv Dongqing)
  • Sun Yat-sen University Cancer Center, Guangzhou, China

    Contact: Study coordinator (xu ruihua)
  • The First Affiliated Hospital, Zhejiang University School Of Medicine, Hangzhou, China

    Contact: Study coordinator (Zhao qingwei)
    Contact: Principal Investigator (Fang weijia)
    Contact: Principal Investigator (Zhao qingwei)
  • Cancer Hospital of Shandong First Medical University, Jinan, China

    Contact: Study coordinator (Zhang yan)
    Contact: Principal Investigator (Wang linlin)
    Contact: Principal Investigator (Zhang yan)
  • Jinan Central Hospital, Jinan, China

    Contact: Study coordinator (Wen qing)
    Contact: Principal Investigator (Sun meili)
    Contact: Principal Investigator (Wen qing)
  • Shanxi Cancer Hospital, Taiyuan, China

    Contact: Study coordinator (Wang xin)
  • Henan Cancer Hospital, Zhengzhou, China

    Contact: Study coordinator (Luo suxia)